APA (7th ed.) Citation

Kuwano, A., Yada, M., Nagasawa, S., Tanaka, K., Morita, Y., Masumoto, A., & Motomura, K. (2022). Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment. Journal of Viral Hepatitis, 29(1), 35. https://doi.org/10.1111/jvh.13625

Chicago Style (17th ed.) Citation

Kuwano, Akifumi, Masayoshi Yada, Shigehiro Nagasawa, Kosuke Tanaka, Yusuke Morita, Akihide Masumoto, and Kenta Motomura. "Serum α‐fetoprotein Level at Treatment Completion Is a Useful Predictor of Hepatocellular Carcinoma Occurrence More than One Year After Hepatitis C Virus Eradication by Direct‐acting Antiviral Treatment." Journal of Viral Hepatitis 29, no. 1 (2022): 35. https://doi.org/10.1111/jvh.13625.

MLA (9th ed.) Citation

Kuwano, Akifumi, et al. "Serum α‐fetoprotein Level at Treatment Completion Is a Useful Predictor of Hepatocellular Carcinoma Occurrence More than One Year After Hepatitis C Virus Eradication by Direct‐acting Antiviral Treatment." Journal of Viral Hepatitis, vol. 29, no. 1, 2022, p. 35, https://doi.org/10.1111/jvh.13625.